Cocaine-Induced PEA Arrest in End-Stage Heart Failure: A Diagnostic Pitfall

Cocaine use is linked to significant cardiovascular toxicity that can lead to heart failure, increased mortality, and complex clinical emergencies such as pulseless electrical activity (PEA) arrest. Recent medical literature highlights the severe impact of cocaine on the heart, noting its role as an established cardiovascular toxin that complicates the management of end-stage heart failure.

Research indicates that cocaine-induced cardiotoxicity occurs through both direct and indirect mechanisms. Directly, the substance inhibits sodium channels. Indirectly, it inhibits the uptake of catecholamines, which leads to increased sympathetic activity in the body.

Clinical Outcomes and Mortality Risks

The impact of cocaine use on patients with heart failure (HF) is marked by a higher risk of death and hospital readmission. A retrospective cohort study conducted between 2001 and 2019 analyzed 738 cocaine users and compared them with 738 matched nonusers to determine the influence of the drug on clinical outcomes.

The findings revealed that cocaine use was associated with an increased risk of all-cause mortality, with an adjusted hazard ratio of 1.21. The study also identified a higher rate of 90-day readmissions for both all-cause reasons and heart failure specifically, with an adjusted hazard ratio of 1.49 for both categories. These increased risks persisted at the one-year mark.

Management of Heart Failure with Reduced Ejection Fraction

For patients suffering from heart failure with reduced ejection fraction (HFrEF) who also use cocaine, the use of beta-blockers has been a point of clinical evaluation. Beta-blockers are standard treatments for HFrEF, but their safety in the context of cocaine use has required specific study.

The data suggests that both nonselective and selective beta-blockers may be safely tolerated in this patient population. In the cohort study, patients prescribed metoprolol, carvedilol, or no beta-blocker at the time of discharge showed similar rates of 30-day readmission and one-year mortality.

Complex Complications and Diagnostic Challenges

The intersection of substance abuse and end-stage heart failure can lead to critical events such as pulseless electrical activity (PEA) arrest. This condition occurs when the heart’s electrical system continues to function, but the muscle fails to pump blood effectively, resulting in a lack of a detectable pulse.

In severe cases, cocaine-associated cardiotoxicity can be further complicated by cerebellar infarction. The presence of such neurological events following resuscitation can create diagnostic pitfalls for medical professionals, complicating the post-resuscitation care and assessment of the patient.

Heart failure remains a complex clinical syndrome characterized by high morbidity and mortality. While it has a variety of etiologies, the direct cardiotoxic effects of cocaine contribute to a major public healthcare problem by exacerbating heart dysfunction and increasing the likelihood of sudden cardiac arrest.